Orly Spiegler

Orly Spiegler is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of neuroscience, particularly in the area of axonal regeneration. With a total of 3 patents to his name, Spiegler's work focuses on innovative methods and compositions that utilize mononuclear phagocytes to promote healing in the central nervous system.

Latest Patents

One of Spiegler's latest patents involves the use of allogeneic mononuclear phagocytes to enhance axonal regeneration in mammals. The patent outlines methods for culturing these phagocytes with stimulatory tissue, such as skin or nerve segments, before administering them to the central nervous system at sites of injury or disease. Additionally, the patent describes alternative methods using autologous monocytes, particularly stimulated ones, for similar therapeutic purposes. The invention also includes methods for screening stimulatory tissues and cells, as well as compositions for cryopreserved allogeneic mononuclear phagocytes.

Career Highlights

Orly Spiegler is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in regenerative medicine. His innovative approaches have the potential to significantly impact treatments for central nervous system injuries.

Collaborations

Spiegler has collaborated with notable colleagues, including Michal Eisenbach-Schwartz and David L. Hirschberg. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Orly Spiegler's work in the field of axonal regeneration exemplifies the intersection of innovation and medical science. His contributions are paving the way for new treatments that could improve recovery outcomes for individuals with central nervous system injuries.